BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Company Registration Number:
08903245 (England and Wales)

Unaudited abridged accounts for the year ended 31 January 2026

Period of accounts

Start date: 01 February 2025

End date: 31 January 2026

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Contents of the Financial Statements

for the Period Ended 31 January 2026

Balance sheet
Notes

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Balance sheet

As at 31 January 2026


Notes
2026
2025


£
£
Called up share capital not paid: 0 0
Fixed assets
Tangible assets: 3 19,153 27,605
Investments: 4 95,000 95,000
Total fixed assets: 114,153 122,605
Current assets
Debtors:   53,877 3,219
Cash at bank and in hand: 104,798 96,430
Total current assets: 158,675 99,649
Creditors: amounts falling due within one year: 5 (119,683) (112,643)
Net current assets (liabilities): 38,992 (12,994)
Total assets less current liabilities: 153,145 109,611
Total net assets (liabilities): 153,145 109,611
Capital and reserves
Called up share capital: 166 166
Profit and loss account: 152,979 109,445
Shareholders funds: 153,145 109,611

The notes form part of these financial statements

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Balance sheet statements

For the year ending 31 January 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 21 October 2026
and signed on behalf of the board by:

Name: Nipun Gupta
Status: Director

The notes form part of these financial statements

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

2. Employees

2026 2025
Average number of employees during the period 8 7

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

3. Tangible Assets

Total
Cost £
At 01 February 2025 49,383
Additions 1,063
At 31 January 2026 50,446
Depreciation
At 01 February 2025 21,778
Charge for year 9,515
At 31 January 2026 31,293
Net book value
At 31 January 2026 19,153
At 31 January 2025 27,605

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

4. Fixed investments

investment into the joint venture

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

5. Creditors: amounts falling due within one year note

Usual Trade debtors and Taxes

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

6. Financial commitments

Going Concern - cash reserves maintained for liabilities.

BRACEY'S ACCOUNTANTS (MEDICAL) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2026

7. Related party transactions

Name of the related party:
Relationship:
Directorship
Description of the Transaction: Loan to invest in the joint venture
£
Balance at 01 February 2025 95,000
Balance at 31 January 2026 95,000